AI-generated summary
The authors reviewed published studies, guidelines and consensus statements from 2000 to March 2026 on electrotherapy in cancer rehabilitation. They report the strongest support for TENS, photobiomodulation, neuromuscular electrical stimulation, Deep Oscillation Therapy and shock wave therapy for selected supportive uses, with other modalities showing limited or no oncology-specific evidence. The review frames electrotherapy as a prescription-based intervention that requires careful indication and dosing.
- Who or what was studied
- Adults with cancer or cancer survivors receiving oncology rehabilitation
- Limits stated in the abstract
- The abstract describes a narrative review and does not report the number of included studies or quantify the strength of the evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background/Objectives
As cancer survival improves, rehabilitation has become an increasingly important component of comprehensive oncology care, addressing the growing burden of treatment-related impairments. Although electrotherapy modalities are widely used in Physical and Rehabilitation Medicine, their application in oncology remains controversial because of persistent concerns regarding safety and potential interactions with tumor biology. This narrative review critically evaluates the current evidence regarding the clinical applications, safety, contraindications, and therapeutic potential of electrotherapy modalities in oncology rehabilitation.
Methods
A structured literature search was performed in PubMed, Scopus, and Web of Science for studies published between January 2000 and March 2026. Evidence from randomized controlled trials, observational studies, systematic reviews, meta-analyses, clinical practice guidelines, consensus statements, and narrative reviews was analyzed.
Results
The strongest clinical evidence supports transcutaneous electrical nerve stimulation (TENS), photobiomodulation (PBM)/low-level laser therapy (LLLT), neuromuscular and functional electrical stimulation (NMES/FES), Deep Oscillation Therapy, and extracorporeal shock wave therapy (ESWT) for selected supportive indications in oncology rehabilitation. Therapeutic ultrasound, pulsed electromagnetic field therapy (PEMF), repetitive transcranial magnetic stimulation (rTMS), Multiwave Locked System (MLS) laser, and shortwave diathermy show promising but still limited clinical evidence, whereas oncology-specific evidence remains insufficient for interferential currents, diadynamic currents, high-intensity laser therapy (HILT), Super Inductive System (SIS), and transfer of capacitive and resistive energy (TECAR) therapy.
Conclusions
Electrotherapy in oncology rehabilitation should be considered a prescription-based therapeutic intervention rather than a group of interchangeable physical modalities. As with pharmacological therapy, treatment efficacy and safety depend on selecting the appropriate modality, establishing the correct indication, and prescribing appropriate dosimetry and treatment parameters. Current evidence supports an individualized, evidence-informed approach that integrates the biological effects of each modality with the patient's oncological status, rehabilitation goals, and overall clinical condition, with the ultimate aim of improving function, symptom control, and quality of life.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, High-intensity laser therapy, Low-level laser therapy, Photobiomodulation, Transcranial magnetic stimulation, Dosimetry. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.